Table 5 Variable importance 1 year HF hospitalisation
Feature | Description feature | N | Univariate | Random forest | Elastic net | Logistic regression |
|---|---|---|---|---|---|---|
OR* | (MSE†) | (coefficients) | (predictor) | |||
dbc_2014_099899068 | > 5 Nursing days acuut CHF | 753 | 4.5 | 0.00055 | 0.66195 | 0.74370 |
dbc_2014_099899024 | < 6 Nursing days acuut HF | 674 | 3.9 | 0.00005 | 0.50642 | 0.84080 |
dbc_2014_099899046 | < 6 Nursing days CHF | 1692 | 2.7 | 0.00022 | 0.48950 | |
zrg_2014_OX04070489 | DBC laboratory research | 2656 | 1.2 | 0.00015 | ||
zrg_2012_OX02070820 | BNP/NT-proBNP Laboratory research | 3130 | 1.2 | 0.00011 | ||
DRG_2012_C64_C68 | Malignant neoplasm of urinary tract | 553 | 1.5 | 0.00009 | ||
zrg_2014_500112001 | Consult GP > 20 min | 12,488 | 1.1 | 0.00009 | ||
ATC_2014_C09AA02 | Enalapril/enalaprilaat | 1996 | 1.3 | 0.00009 | ||
zrg_2012_U46012300 | Consult GP | 5086 | 1.2 | 0.00006 | ||
dbc_2012_099899003 | Surgical team meeting and/or outpatient clinic visit in case of a disease of the heart | 1112 | 1.8 | 0.00005 | ||
dbc_2012_131999206 | Outpatient clinical visit rheumatism | 401 | 0.6 | 0.57427 | 1.56740 | |
ATC3_2014_A01 | Mouth preparations | 280 | 1.8 | 0.50668 | 0.82770 | |
DRG_2012_C81_C96 | Malignant neoplasm lymphoid and blood-forming tissue | 690 | 1.5 | 0.42163 | 0.72440 | |
ATC_2012_R03AC12 | Salmeterol | 344 | 0.8 | 0.53758 | 0.70620 | |
zrg_2012_OX04080080 | DBC Radiology | 269 | 0.1 | 0,67,103 | ||
ATC_2014_C09AA01 | Captopril | 291 | 0.9 | 0,46,435 | ||
dbc_2014_099899050 | > 5 Nursing days acuut HF | 977 | 4.0 | 0,43,989 | ||
zrg_2012_701013016 | Post-operative consultation inc. removal of suture material, in practice GP aid | 602 | 0.7 | 1.11550 | ||
DRG_2012_C64_C68 | Malignant neoplasm of urinary tract | 553 | 1.5 | 0.99730 | ||
dbc_2012_079999013 | Outpatient clinic visit eye disease | 333 | 0.8 | 0.76760 | ||
dbc_2012_100501045 | Day treatment asthma | 353 | 1.1 | 0.68920 |